David C. Marek - Oct 18, 2022 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Principal Executive Officer, Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Oct 18, 2022
Transactions value $
-$281,131
Form type
4
Date filed
10/20/2022, 04:53 PM
Previous filing
Jul 20, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$281K -11.2K -2.55% $25.20 426K Oct 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.